Clinical Trials Browser

Phase 3 × Terminated × anlotinib × Clear all

NCT03866980 2024-04-03

A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung